JBC INTERFERin siRNA transfection reagent

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


A more recent version of this article appeared on March 7, 2008
This Article
Right arrow Full Text (Accepted Manuscript)
Right arrow All Versions of this Article:
283/10/6022    most recent
M703432200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Walsh, H.
Right arrow Articles by Green, W. N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Walsh, H.
Right arrow Articles by Green, W. N.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Papers In Press, published online ahead of print January 3, 2008
J. Biol. Chem, 10.1074/jbc.M703432200
Submitted on April 24, 2007
Revised on January 2, 2008
Accepted on January 3, 2008

Upregulation of nicotinic receptors by nicotine varies with receptor subtype

Heather Walsh, Anitha P. Govind, Ryan Mastro, J. C. Hoda, Daniel Bertrand, Yolanda Vallejo, and William N. Green

Neurobiology, University of Chicago, Chicago, IL 60657

Corresponding Author: wgreen{at}midway.uchicago.edu

Recent evidence suggests that in addition to A4B2 and A3-containing nicotinic receptors, A6-containing receptors are present in midbrain dopaminergic neurons and involved in the nicotine reward pathway. Using heterologous expression, we found that A6B2, like A3B2 and A4B2 receptors, formed high-affinity, epibatidine–binding complexes that are pentameric, trafficked to the cell surface and produced acetylcholine-evoked currents. Chronic nicotine exposure upregulated A6B2 receptors with differences in upregulation time course and concentration-dependence compared to A4B2 receptors, the predominant high-affinity nicotine binding site in brain. The A6B2 receptor upregulation required higher nicotine concentrations than for A4B2 but was 10-fold faster and more comparable to that of A3B2. Our data suggest that nicotinic receptor upregulation is subtype specific such that A6/A3-containing receptors upregulate in response to transient, high nicotine exposures while sustained, low nicotine exposures upregulate A4B2 receptors.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Mol. Pharmacol.Home page
X. A. Perez, T. Bordia, J. M. McIntosh, S. R. Grady, and M. Quik
Long-Term Nicotine Treatment Differentially Regulates Striatal {alpha}6{alpha}4{beta}2* and {alpha}6(Non{alpha}4){beta}2* nAChR Expression and Function
Mol. Pharmacol., September 1, 2008; 74(3): 844 - 853.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2008 by the American Society for Biochemistry and Molecular Biology.